Promising Alzheimer’s Therapy: Blarcamesine Shows Positive Results in Latest Trials
Anavex Life Sciences has announced encouraging results from its Phase 2b/3 clinical trial of blarcamesine, an investigational oral therapy for early-stage Alzheimer’s disease. The study, […]